Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide.
about
Palmitoylethanolamide reduces granuloma-induced hyperalgesia by modulation of mast cell activation in ratsBiochanin A, a naturally occurring inhibitor of fatty acid amide hydrolaseTreatment of chronic regional pain syndrome type 1 with palmitoylethanolamide and topical ketamine cream: modulation of nonneuronal cells.Advances in the discovery of N-acylethanolamine acid amidase inhibitorsPalmitoylethanolamide for the treatment of pain: pharmacokinetics, safety and efficacyModulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamideAntiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the ratPalmitoylethanolamide counteracts reactive astrogliosis induced by β-amyloid peptideDesign and synthesis of potent N-acylethanolamine-hydrolyzing acid amidase (NAAA) inhibitor as anti-inflammatory compoundsAmino Acid Derivatives as Palmitoylethanolamide Prodrugs: Synthesis, In Vitro Metabolism and In Vivo Plasma Profile in RatsBiosynthesis of anandamide and N-palmitoylethanolamine by sequential actions of phospholipase A2 and lysophospholipase DThe pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations.Enhancement of antinociception by coadministration of minocycline and a non-steroidal anti-inflammatory drug indomethacin in naïve mice and murine models of LPS-induced thermal hyperalgesia and monoarthritisAdministration of URB597, oleoylethanolamide or palmitoylethanolamide increases waking and dopamine in rats.Mass spectrometric characterization of human N-acylethanolamine-hydrolyzing acid amidase.The association of N-palmitoylethanolamine with the FAAH inhibitor URB597 impairs melanoma growth through a supra-additive action.Palmitoylethanolamide protects against the amyloid-β25-35-induced learning and memory impairment in mice, an experimental model of Alzheimer disease.The endocannabinoid system and painPeroxisome proliferator-activated receptor α mediates acute effects of palmitoylethanolamide on sensory neuronsTherapeutic effect of the endogenous fatty acid amide, palmitoylethanolamide, in rat acute inflammation: inhibition of nitric oxide and cyclo-oxygenase systems.The expanding field of cannabimimetic and related lipid mediators.Cellular viability effects of fatty acid amide hydrolase inhibition on cerebellar neuronsAnandamide suppresses pain initiation through a peripheral endocannabinoid mechanism.Synergistic antinociception by the cannabinoid receptor agonist anandamide and the PPAR-alpha receptor agonist GW7647.Activity-Based Probe for N-Acylethanolamine Acid Amidase.The effect of the palmitoylethanolamide analogue, palmitoylallylamide (L-29) on pain behaviour in rodent models of neuropathyBiological activity of plant extracts: novel analgesic drugs.Mast cell-glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide.Cannabinoids: a new group of agonists of PPARs.Inhibitory properties of ibuprofen and its amide analogues towards the hydrolysis and cyclooxygenation of the endocannabinoid anandamide.Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing-Remitting Multiple Sclerosis.The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB₁- and FAAH-independent mechanisms.Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain.Glucocorticoids shift arachidonic acid metabolism toward endocannabinoid synthesis: a non-genomic anti-inflammatory switch.Comparative metabolomics of muscle interstitium fluid in human trapezius myalgia: an in vivo microdialysis studyTargeting CB2 receptors and the endocannabinoid system for the treatment of pain.A role for PPARα in the medial prefrontal cortex in formalin-evoked nociceptive responding in rats.Antihyperalgesic Activities of Endocannabinoids in a Mouse Model of Antiretroviral-Induced Neuropathic Pain.Deciphering the mechanism(s) of action of natural products: analgesic peroxide oil as example.Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator.
P2860
Q21203937-E92F33EF-E288-498B-866A-21A96571357FQ24620186-5288092A-44F4-47C5-AF4D-E8B2FD4DA04CQ24630453-0B4DA9EA-064F-492C-BC7E-124862C4C4C5Q26866274-C9408C0E-68FE-49E8-AB88-396281498C8CQ28066248-1F30D6E4-F3BB-490E-BB51-26DE54DC4ECCQ28248981-49514659-5B67-4F22-8F73-0197B6AFC091Q28344879-18A01C75-F7AD-4B02-9BC0-8F97FDFB0669Q28390536-AD2B70AE-C23A-4539-9771-84A4FB50609DQ28482428-6EFC7BE6-EB5F-43DA-A615-144E01C50ABDQ28548007-FE61B26E-3299-48B8-A9CD-D37C4B239175Q28581971-E7D793CB-ACBA-4938-8913-BAD1EE3E2D2DQ31122398-3665C9E9-6B14-4B72-8360-D3F9DE45876DQ33759886-9C342391-7ECC-47CD-B39E-1433253434FFQ33968029-C06C3EB5-C7E0-4011-AEBE-F33F21E158B3Q34062823-D2CF4490-860C-40E4-8CA8-4510EA30D26EQ34202076-61086050-F33D-4E28-9804-0EAECEB6D860Q34261073-E9B66F03-4D41-4354-AC68-C5BEEF167180Q34612917-E3E27D7C-3DD3-4EB1-9367-1B421444AB7CQ34642573-50BE5BD9-7EED-49D4-BD89-76187002B509Q35044663-780173B6-B758-48F0-B787-796EBB8EFAF2Q35048658-2E6D1858-6238-4963-933F-2EB38B5B9CCBQ35208884-C68367C2-174C-4C63-9CDD-8C9FC1A3CFB4Q35678770-7CBBC6E7-63D3-4213-9755-665C92728707Q36019444-C4AEAA71-255E-4669-9568-F915ED681525Q36074423-73E72010-A0A3-4F8D-B2A8-E0A0D6B60F42Q36094329-1FC2BBBF-AC47-4966-9CB8-DFAB4141EBAFQ36179675-1F711E5F-65E2-4001-8111-EEF06424AF78Q36348374-0F8A855E-8852-468B-AAD7-6D3B77511983Q36417528-25F65DC4-4CB3-4509-A716-A81D0C588365Q36712224-01A46B97-607C-49F0-8EBC-A56926E0382EQ36775237-5B4D7A92-5AD1-4A92-8B85-59DFC9EE5350Q36943239-05EFDA24-D2DB-43C8-B926-539EADA0390DQ36997712-0469EF0B-4224-4B19-853C-45DF97DAF11DQ37092760-212A998C-C90A-434D-9C5D-CF4691EEADF9Q37309640-51C69AB1-3EFD-4A66-916F-547A4FB2944FQ37371095-527361A6-D9AC-41BA-9EDA-BDCFC6714772Q37637765-CFC9528C-69BA-4C45-96A8-94582D3C5264Q37710345-BA3C86DF-768D-42B8-A478-8FE8CF7BB4F9Q37872360-4AB9AB42-361E-4B9F-BD8B-83E5D566D643Q38118187-E5CD7F40-BA23-4BCE-BC6E-AF5037F81959
P2860
Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide.
@ast
Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide.
@en
type
label
Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide.
@ast
Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide.
@en
prefLabel
Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide.
@ast
Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide.
@en
P1476
Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide
@en
P2093
P304
P356
10.1016/S0014-2999(01)00988-8
P407
P577
2001-05-01T00:00:00Z